Alliance Magazine: On the journey to equitable philanthropy

Written By Charlotte Vangsgaard

By Ujjwal Gupta and Charlotte Vangsgaard

Why pharma needs to focus on improving—not just extending life.

There are no market incentives for building a practical roadmap to this change. Philanthropists have to fund and deploy it, and those who do will emerge as the philanthropic role models of tomorrow. Those who don’t, risk their goodwill, a public backlash, and at worst, perpetuating, not solving, inequities.

Read the full article on Alliance Magazine.

Charlotte Vangsgaard

Charlotte is focused on driving social impact in both nonprofit and commercial organizations. Across her diverse set of clients from iconic luxury goods to healthcare, Charlotte specializes in deriving commercial value from a strategy aligned around social possibilities. Today she is also spearheading change management strategies at some of the world’s largest foundations and corporations. All of her client work—as well as her most recent writing—explores innovative ways to apply social science theory to business problems.

Before joining ReD, Charlotte drove projects on poverty alleviation and economic development for the United Nations Development Programme in Cairo and Algiers before moving on to work for the Danish Government and the International Center for Corporate Accountability. She holds an MBA in International Business and Marketing and a Masters in Political Science.

Next

Pharmaceutical Executive: Thriving ‘Beyond the Pill’: Closing Key Gap in Patient Support